These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

276 related items for PubMed ID: 10599380

  • 1. Increased reduction in bone density and skin thickness in postmenopausal women on long-term corticosteroid therapy. A suggested role for estrogen add back therapy.
    Baron YM, Brincat M, Galea R.
    Adv Exp Med Biol; 1999; 455():429-36. PubMed ID: 10599380
    [Abstract] [Full Text] [Related]

  • 2. Increased reduction in bone density and skin thickness in postmenopausal women taking long-term corticosteroid therapy: a suggested role for estrogen add-back therapy.
    Baron YM, Brincat MP, Galea R.
    Climacteric; 1999 Sep; 2(3):189-96. PubMed ID: 11910596
    [Abstract] [Full Text] [Related]

  • 3. Corticosteroid effects on proximal femur bone loss.
    Sambrook P, Birmingham J, Kempler S, Kelly P, Eberl S, Pocock N, Yeates M, Eisman J.
    J Bone Miner Res; 1990 Dec; 5(12):1211-6. PubMed ID: 2075834
    [Abstract] [Full Text] [Related]

  • 4. Bone health in urban midlife Malaysian women: risk factors and prevention.
    Lim PS, Ong FB, Adeeb N, Seri SS, Noor-Aini MY, Shamsuddin K, Hapizah N, Mohamed AL, Mokhtar A, Wan HW.
    Osteoporos Int; 2005 Dec; 16(12):2069-79. PubMed ID: 16234999
    [Abstract] [Full Text] [Related]

  • 5. Differential effects of estrogen treatment on bone mineral density of the spine, hip, wrist and total body in late postmenopausal women.
    Kohrt WM, Birge SJ.
    Osteoporos Int; 1995 May; 5(3):150-5. PubMed ID: 7655174
    [Abstract] [Full Text] [Related]

  • 6. Two to three years of hormone replacement treatment in healthy women have long-term preventive effects on bone mass and osteoporotic fractures: the PERF study.
    Bagger YZ, Tankó LB, Alexandersen P, Hansen HB, Møllgaard A, Ravn P, Qvist P, Kanis JA, Christiansen C.
    Bone; 2004 Apr; 34(4):728-35. PubMed ID: 15050905
    [Abstract] [Full Text] [Related]

  • 7. Parathyroid hormone treatment can reverse corticosteroid-induced osteoporosis. Results of a randomized controlled clinical trial.
    Lane NE, Sanchez S, Modin GW, Genant HK, Pierini E, Arnaud CD.
    J Clin Invest; 1998 Oct 15; 102(8):1627-33. PubMed ID: 9788977
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Relation of aromatase gene polymorphism and hormone replacement therapy to serum estradiol levels, bone mineral density, and fracture risk in early postmenopausal women.
    Salmen T, Heikkinen AM, Mahonen A, Kröger H, Komulainen M, Pallonen H, Saarikoski S, Honkanen R, Mäenpää PH.
    Ann Med; 2003 Oct 15; 35(4):282-8. PubMed ID: 12846271
    [Abstract] [Full Text] [Related]

  • 10. Withdrawal of hormone replacement therapy is associated with significant vertebral bone loss in postmenopausal women.
    Trémollieres FA, Pouilles JM, Ribot C.
    Osteoporos Int; 2001 Oct 15; 12(5):385-90. PubMed ID: 11444087
    [Abstract] [Full Text] [Related]

  • 11. Does vitamin D strengthen the increase in femoral neck BMD in osteoporotic women treated with estrogen?
    Tuppurainen MT, Komulainen M, Kröger H, Honkanen R, Jurvelin J, Puntila E, Heikkinen AM, Alhava E, Saarikoski S.
    Osteoporos Int; 1998 Oct 15; 8(1):32-8. PubMed ID: 9692075
    [Abstract] [Full Text] [Related]

  • 12. Randomised controlled study of effect of parathyroid hormone on vertebral-bone mass and fracture incidence among postmenopausal women on oestrogen with osteoporosis.
    Lindsay R, Nieves J, Formica C, Henneman E, Woelfert L, Shen V, Dempster D, Cosman F.
    Lancet; 1997 Aug 23; 350(9077):550-5. PubMed ID: 9284777
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Prospective 10-year study of the determinants of bone density and bone loss in normal postmenopausal women, including the effect of hormone replacement therapy.
    Wu F, Ames R, Clearwater J, Evans MC, Gamble G, Reid IR.
    Clin Endocrinol (Oxf); 2002 Jun 23; 56(6):703-11. PubMed ID: 12072039
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Thyroid hormone use and bone mineral density in elderly women. Effects of estrogen.
    Schneider DL, Barrett-Connor EL, Morton DJ.
    JAMA; 1994 Apr 27; 271(16):1245-9. PubMed ID: 7848399
    [Abstract] [Full Text] [Related]

  • 17. The effect of clodronate and antioestrogens on bone loss associated with oestrogen withdrawal in postmenopausal women with breast cancer.
    Saarto T, Vehmanen L, Elomaa I, Välimäki M, Mäkelä P, Blomqvist C.
    Br J Cancer; 2001 Apr 20; 84(8):1047-51. PubMed ID: 11308252
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Effect of estrogen replacement therapy upon bone mineral density in thyroxine-treated postmenopausal women with a past history of thyrotoxicosis.
    Franklyn JA, Betteridge J, Holder R, Sheppard MC.
    Thyroid; 1995 Oct 20; 5(5):359-63. PubMed ID: 8563472
    [Abstract] [Full Text] [Related]

  • 20. Long-term postmenopausal hormone replacement therapy effects on bone mass: differences between surgical and spontaneous patients.
    Castelo-Branco C, Figueras F, Sanjuan A, Pons F, Vicente JJ, Vanrell JA.
    Eur J Obstet Gynecol Reprod Biol; 1999 Apr 20; 83(2):207-11. PubMed ID: 10391534
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.